12:01 PM EST - StageZero Life Sciences Ltd : Is offering the Company's proprietary mRNA Liquid Biopsy test for Early Colorectal Cancer Detection to U.S. consumers through its online store. ColonSentry® is a blood test that measures the risk/probability of a patient having Colorectal Cancer now. StageZero Life Sciences Ltd
shares T.SZLS are trading unchanged at $0.08.
